Eilmeldung
RUBelarus Protests Ukrainian Drone Attack on Bus Carrying ChildrenINIndia's Navy Needs More Anti-Submarine Warfare HelicoptersCNChina's Private Jet Exodus Stabilizes Amid Shifting DemandINNew Zealand Weathering England's Attack in First Hour After LunchCNHong Kong University Town Plan Delayed, Awaiting City's First Five-Year PlanINTLGuinea-Bissau Opposition Leader's House Arrest Becomes International IssueRUNetanyahu Vows Strong Response to Hezbollah Attacks, Vows to Remain in Southern LebanonINTLFormer Medieval Times "Queen" Sues for Retaliation After Reporting HarassmentRUPhilippines Interested in Russia Cooperation in Innovation and Nuclear PowerINTLOil Prices Fall as Israel, Hezbollah Agree to Ceasefire; U.S.-Iran Talks CanceledRUBelarus Protests Ukrainian Drone Attack on Bus Carrying ChildrenINIndia's Navy Needs More Anti-Submarine Warfare HelicoptersCNChina's Private Jet Exodus Stabilizes Amid Shifting DemandINNew Zealand Weathering England's Attack in First Hour After LunchCNHong Kong University Town Plan Delayed, Awaiting City's First Five-Year PlanINTLGuinea-Bissau Opposition Leader's House Arrest Becomes International IssueRUNetanyahu Vows Strong Response to Hezbollah Attacks, Vows to Remain in Southern LebanonINTLFormer Medieval Times "Queen" Sues for Retaliation After Reporting HarassmentRUPhilippines Interested in Russia Cooperation in Innovation and Nuclear PowerINTLOil Prices Fall as Israel, Hezbollah Agree to Ceasefire; U.S.-Iran Talks Canceled
Newsgather

drugmakers

Stabil11 Meldungen4 QuellenZuletzt aktualisiert: 6 g önce
Verwandte ThemenpharmaceuticalsFDAdrug pricingobesity drugsGLP-1weight lossdrug developmentAmerican Diabetes Association

Neueste Meldungen

Drugmakers Envision Future of Obesity Treatments Beyond GLP-1s
In Entwicklung
Gesundheit·6 g önceKI-Zusammenfassung

Drugmakers Envision Future of Obesity Treatments Beyond GLP-1s

Drugmakers are exploring new obesity treatments beyond GLP-1s, including less frequent shots and pills with fewer side effects. Eli Lilly's experimental drug retatrutide showed significant weight loss, while competitors like Novo Nordisk, Structure Therapeutics, AstraZeneca, Pfizer, and Amgen are developing new oral and injectable options. The market is expected to grow significantly, with pricing and insurance coverage being key factors.

C
CNBC US Markets
Regeneron Cuts Drug Prices for Some Americans in Trump Deal, Offers Free Gene Therapy
In Entwicklung
Gesundheit·23.04.2026KI-Zusammenfassung

Regeneron Cuts Drug Prices for Some Americans in Trump Deal, Offers Free Gene Therapy

Regeneron agreed to lower U.S. drug prices for some Americans under a deal with President Trump, part of his 'most favored nation' effort to align U.S. prices with lower international rates. The biotech company will also offer its newly FDA-approved hearing-loss gene therapy Otarmeni for free to eligible patients. The agreements exempt companies from tariffs for three years, including planned up to 100% levies on pharmaceuticals. The FDA approved Otarmeni under its National Priority Voucher program for an ultra-rare genetic condition causing deafness.

C
CNBC